Publication | Open Access
Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)
12
Citations
63
References
2023
Year
MedicineImmunologyAntiviral Drug DevelopmentAntiviral TherapyVirologyKorupensamine BAntiviral DrugPharmacologyAntiviral CompoundMain ProteaseDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1